11/7/26 Retention by Design - Keeping Families Engaged for Multi-Year Studies Previous Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Next Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity You Might Also Like Leveraging Natural History and RWE for Rare Approvals From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Inside the FDA Mindset - Negotiating Endpoints and Surrogates Modeling Value Across the Rare Disease Patient Journey Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity
11/7/26 Retention by Design - Keeping Families Engaged for Multi-Year Studies Previous Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Next Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity You Might Also Like Leveraging Natural History and RWE for Rare Approvals From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Inside the FDA Mindset - Negotiating Endpoints and Surrogates Modeling Value Across the Rare Disease Patient Journey Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity
